Cardiac Triple
- UID
- IMP/IVD/2021/000365_e75de94916bc5c20c62ef7bbf514d695_d0f6d6ad86976e9c51bd26cd9b6fdced
- Device class
- Class C
- Brand name
- AFIAS ST2
- License holder
- BODITECH MED INDIA PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- AFIAS Cardiac Triple is a Fluorescence Immunoassay ( AFIAS ST2) for the quantitative determination of cardiac troponin-I ( AFIAS ST2), Creatine kinase ( AFIAS ST2) and Myoglobin in human whole blood/serum/plasma Troponin-I, CK-MB, and Myoglobin value are used to assist in the diagnosis of acute myocardial infarction ( AFIAS ST2) and acute coronary syndrome ( AFIAS ST2)
Cardiac Triple is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_e75de94916bc5c20c62ef7bbf514d695_d0f6d6ad86976e9c51bd26cd9b6fdced. This device is marketed under the brand name AFIAS ST2. The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.